Shared equipment – Page 7

How to Strengthen Cleaning SOPs After Cross-Contamination Deviations

Strengthening Cleaning Standard Operating Procedures (SOPs) After Cross-Contamination Deviations In the sphere of pharmaceutical manufacturing, maintaining cleanliness standards is paramount. Cross-contamination deviations can pose significant risks to product integrity, leading…

Worst-Case Product Selection for Packaging Contact Parts and Change Parts

Addressing Challenges in Selecting Worst-Case Products for Packaging Contact Parts In the pharmaceutical manufacturing environment, selecting the appropriate worst-case products for packaging contact parts is critical for ensuring product integrity…

Worst-Case Product Selection for Packaging Contact Parts and Change Parts

Effective Strategies for Worst-Case Product Selection in Packaging Contact Parts In the pharmaceutical manufacturing environment, ensuring that packaging contact parts are appropriately selected for their intended products is critical for…

Cleaning and Cross-Contamination Audit Findings: Common GMP Gaps

Audit Findings on Cleaning and Cross-Contamination: Identifying Common GMP Gaps In the highly regulated pharmaceutical environment, cleaning and cross-contamination control are vital to ensure product quality and compliance. Recent audits…

Worst-Case Product Selection for Suspensions and Syrups in Liquid Manufacturing

Worst-Case Product Selection Techniques for Liquid Manufacturing in Pharma Pharmaceutical manufacturers often face challenges when selecting worst-case products for suspensions and syrups during liquid manufacturing. The failure to adequately assess…

Worst-Case Product Selection for Suspensions and Syrups in Liquid Manufacturing

Strategies for Managing Worst-Case Product Selection in Liquid Manufacturing In pharmaceutical manufacturing, particularly in the production of suspensions and syrups, inadequate worst-case product selection can lead to significant contamination risks.…

Cross-Contamination Deviation in High-Potency Manufacturing Areas

Addressing Cross-Contamination Deviations in High-Potency Manufacturing Zones Cross-contamination deviations can significantly impact the integrity, safety, and effectiveness of pharmaceutical products, particularly in high-potency manufacturing areas. These incidents pose a substantial…

Worst-Case Product Selection for Semi-Solids: Ointments, Creams, and Sticky Residues

Addressing Worst-Case Product Selection Challenges for Semi-Solids: A Comprehensive Guide In pharmaceutical manufacturing, particularly with semi-solid formulations such as ointments and creams, ensuring the integrity of cleaning processes is critical.…

How to Investigate Residue Carryover Between Product Campaigns

Effective Investigation of Residue Carryover in Pharmaceutical Manufacturing The challenge of residue carryover between product campaigns poses significant risks for pharmaceutical manufacturers, potentially leading to contamination events that compromise product…

Worst-Case Product Matrix for Tanks, Transfer Lines, and Filling Equipment

Addressing Product Matrix Concerns for Tanks, Transfer Lines, and Filling Equipment In pharmaceutical manufacturing, the appropriate selection of worst-case products is critical for ensuring cleanliness and preventing contamination. Tanks, transfer…

Cleaning Deviation Impact on Next Batch: Investigation and Disposition

Understanding the Impact of Cleaning Deviations on Subsequent Batches: Strategies for Investigation and Remediation The pharmaceutical manufacturing landscape continuously grapples with compliance challenges, particularly concerning cleaning and cross-contamination. Cleaning deviations…

Worst-Case Product Matrix for Shared Blenders, Granulators, and Coating Pans

Identifying and Addressing Worst-Case Product Scenarios in Shared Blenders, Granulators, and Coating Pans In pharmaceutical manufacturing, the utilization of shared equipment such as blenders, granulators, and coating pans presents significant…